
369: Trump, Chinese biotech, and an industry career reshaped by illness
The Readout Loud
00:00
Leadership Shifts at Novo Nordisk
This chapter explores the significant changes introduced by the new CEO of Novo Nordisk, including workforce reductions and a shift in corporate culture. It also examines the implications of these changes on employee morale, the company's performance, and the future of Alzheimer's research involving semaglutide.
Transcript
Play full episode